Cydar Medical has entered a strategic collaboration with Medtronic. Under the pilot arrangement, Cydar’s EV Maps software will be introduced to up to 40 new global sites, combining its augmented intelligence technology with Medtronic’s services and case support, with the goal of improving patient care.
The Cydar EV Maps software harnesses the latest in cloud GPU computing, computer vision and machine learning technology to advance surgical visualisation and decision-making in theatre and across the care pathway. This enables clinicians to create detailed patient-specific 3D maps for procedure planning, image-guided navigation, and post-operative review, resulting in less radiation exposure to the patient and the clinical team, reduced procedure time, and increased delivery confidence.
This pilot program will also inform the future development of predictive analytics to support procedure planning, by assessing factors such as the risk of endoleaks, sac regression probability and more.
The collaboration is part of Medtronic’s ongoing commitment to innovation in aortic care for physicians and their patients.
Carolyn Sleeth, VP, general manager, Aortic, said: “Medtronic aims to revolutionise endovascular aortic treatment with digital solutions with this phased approach. By collecting data across the patient journey—before, during and after procedure—our goal is to provide analytic support to make our endovascular stent grafts ‘smart’.”
Paul Mussenden, CEO of Cydar, added: “By collaborating with Medtronic to bring our Cydar EV Maps solution to up to 40 new hospital sites, we are a step closer to achieving our mission to ensure every image-guided endovascular procedure goes exactly as planned.”
Cydar EV Maps is currently available in the EU, UK and US. It is certified Software-as-a-Medical Device with an EU CE mark and U.S. FDA 510(k) clearance.
